Read how we are working to understand the genetic architecture of each individual person's epilepsy through our world leading genomics research programme.
The future of genomics
Our hope for the future is to find the right treatment, for example the right drug, at the right dosage, from the point of diagnosis. Genomic medicine has the potential to transform the way we care for people with epilepsy, and we believe that whole genome sequencing will help us to unravel the genetic architecture underlying the different types of epilepsy.
We hope it will help us determine the cause of a person’s seizures, their response to anti-epileptic medication and their susceptibility to Sudden Unexpected Death in Epilepsy (SUDEP), and that this will enable us to prescribe more personalised, targeted treatments and reduce the burden that epilepsy places on many people’s lives.
Dr Krithika Iyer Sundararaman, postdoctoral research fellow, using whole exome sequencing technology to read DNA at Epilepsy Society's Chalfont Centre (pictured right).
Find out about our innovative genomics clinic and our pioneering research that is changing the landscape of epilepsy.
Find out how a genetic diagnosis has made a difference to the lives of people with epilepsy.
Meet the team at Epilepsy Society leading the way in global genomics through innovative research techniques. Professor Sanjay Sisodiya, principal investigator of the genomics research programme, oversees a multidisciplinary team of neurologists, biomedical scientists, bioinformaticians, genetics consultants and project managers, who are passionate about translating findings of this ground breaking research to improve the lives of people with epilepsy. Find out more about our principal investigators:
our Ground Breaking
We aim to bring forward the day when epilepsy is not a hidden disability – no longer a stigma that is hidden in the shadows and misunderstood. By giving us your support, you can be part of this journey.
Neuroimaging enables us to look deep inside the brain to learn more about the impact of seizures on its structure and function.
Epidemiology helps us to look at epilepsy in the community and find out who, when and where people have developed the condition.
The Epilepsy Society Brain and Tissue Bank is the first of its kind in the UK. It is dedicated to the study of epilepsy through brain and other tissue samples.